Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Pathology

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2010.090469PMID 20382701PMCID PMC2861089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent*

  2009cited by this paper
• Lymphotoxin‐β receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury

  2009cited by this paper
• Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration*

  2008cited by this paper
• Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis

  2008cited by this paper
• Intermediate filament cytoskeleton of the liver in health and disease

  2008cited by this paper
• TRAIL mediates liver injury by the innate immune system in the bile duct–ligated mouse

  2008cited by this paper
• Gp130 Signaling Promotes Development of Acute Experimental Colitis by Facilitating Early Neutrophil/Macrophage Recruitment and Activation1

  2008cited by this paper
• Transforming growth factor‐beta differentially regulates oval cell and hepatocyte proliferation

  2007cited by this paper
• Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell–mediated liver regeneration

  2007cited by this paper
• A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.

  2007influential reference
• Opposing roles of gp130‐mediated STAT‐3 and ERK‐1/2 signaling in liver progenitor cell migration and proliferation

  2007cited by this paper
• Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats.

  2007cited by this paper
• Bile acids inhibit interleukin‐6 signaling via gp130 receptor‐dependent and ‐independent pathways in rat liver

  2006cited by this paper
• Hepatic expression of the tumor necrosis factor family member lymphotoxin‐β is regulated by interleukin (IL)‐6 and IL‐1β: transcriptional control mechanisms in oval cells and hepatoma cell lines

  2005cited by this paper
• Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.

  2005cited by this paper
• The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.

  2005cited by this paper
• Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.

  2005cited by this paper
• IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

  2005cited by this paper
• In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

  2003cited by this paper
• The origin and liver repopulating capacity of murine oval cells

  2003cited by this paper
• Lack of gp130 expression in hepatocytes promotes liver injury.

  2003cited by this paper
• Interleukin 6/gp130‐dependent pathways are protective during chronic liver diseases

  2003cited by this paper
• Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine Implantation

  2001cited by this paper
• Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL*

  2001cited by this paper
• Hepatocyte‐specific expression of Cre recombinase

  2000cited by this paper
• Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction.

  2000cited by this paper
• The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.

  2000cited by this paper
• Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice

  2000cited by this paper
• Postnatally Induced Inactivation of gp130 in Mice Results in Neurological, Cardiac, Hematopoietic, Immunological, Hepatic, and Pulmonary Defects

  1998cited by this paper
• Impaired immune and acute-phase responses in interleukin-6-deficient mice

  1994cited by this paper

• Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  2025cites this paper
• Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.

  2024cites this paper
• Sortilin in biliary epithelial cells promotes ductular reaction and fibrosis during cholestatic injury.

  2024cites this paper
• The gp130/STAT3-endoplasmic reticulum stress axis regulates hepatocyte necroptosis in acute liver injury

  2023cites this paper
• Response to treatment of murine schistosomiasis with recombinant IL-22 under different circadian timing

  2023cites this paper
• Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism

  2022cites this paper
• Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury

  2022cites this paper
• and control via the Gp130/JAK/STAT3 pathway

  2020cites this paper
• Inflammatory networks cultivate cancer cell metastasis to the liver

  2020cites this paper
• The palmitoyl acyltransferases ZDHHC5 and ZDHHC8 are uniquely present in DRG axons and control retrograde signaling via the Gp130/JAK/STAT3 pathway

  2020cites this paper
• Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin‐induced liver fibrosis and biliary fibrosis in mice

  2019cites this paper
• Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.

  2019cites this paper
• Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway

  2018cites this paper
• The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis

  2018cites this paper
• Catheterization of the gallbladder: A novel mouse model of severe acute cholangitis

  2017cites this paper
• Immunotherapy of Hepatocellular Carcinoma

  2017cites this paper
• Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes.

  2017cites this paper
• A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study

  2017cites this paper
• Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation

  2017cites this paper
• Papel de BMP9 en la patología hepática crónica: estudios "in vivo" e "in vitro"

  2017cites this paper
• Reversal of liver fibrosis: From fiction to reality.

  2017cites this paper
• Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression

  2017cites this paper
• STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

  2016cites this paper
• Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis

  2016cites this paper
• Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3’-methyl-4 dimethylaminoazobenzene in rats

  2015cites this paper
• Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development

  2015cites this paper
• Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction.

  2014cites this paper
• Human growth hormone induced cholestatic hepatitis in a growth hormone deficient patient with short stature.

  2014cites this paper
• STAT3 in hepatocellular carcinoma: new perspectives.

  2014cites this paper
• New Approaches for Studying Alcoholic Liver Disease

  2014cites this paper
• Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis.

  2014cites this paper
• Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.

  2013cites this paper
• Interleukin-6 modulates oxidative stress produced during the development of cisplatin nephrotoxicity.

  2013cites this paper
• STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.

  2013cites this paper
• Differential role of caspase-8 in hepatocytes and non-parenchymal liver cells in a model of chronic liver injury and progenitor cell activation

  2013cites this paper
• Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.

  2012cites this paper
• 940 LOSS OF KERATIN 19 PREDISPOSES TO THE DEVELOPMENT OF CHOLESTATIC LIVER DISEASE

  2012cites this paper
• Einfluss von metabolisch wirksamen Hormonen auf die IL-6-induzierte Signaltransduktion

  2012cites this paper
• Cytokines and STATs in Liver Fibrosis

  2012cites this paper
• Glucocorticoids increase interleukin‐6–dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor

  2012cites this paper
• Xenobiotic-induced liver injury and fibrosis

  2012cites this paper
• Differential Role of gp130-Dependent STAT and Ras Signalling for Haematopoiesis Following Bone-Marrow Transplantation

  2012cites this paper
• Cell Signals Influencing Hepatic Fibrosis

  2012influential citation
• Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation

  2012cites this paper
• Liver regeneration by hepatic progenitor cells

  2011cites this paper
• Will we ever model PSC? - "it's hard to be a PSC model!".

  2011cites this paper
• Glucagon counteracts interleukin-6-dependent gene expression by redundant action of Epac and PKA

  2011cites this paper
• Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target

  2011cites this paper
• JAK-STAT signaling in hepatic fibrosis.

  2011cites this paper
• Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.

  2011cites this paper
• Animal models for the study of liver fibrosis: new insights from knockout mouse models.

  2011cites this paper
• Nrf2 Induces Interleukin-6 (IL-6) Expression via an Antioxidant Response Element within the IL-6 Promoter*

  2010cites this paper